iiinova — where your digital self keeps evolving

Project MOTION @crgmotion.bsky.social · 19/12/2025

🎄✨ Season’s greetings from our team! T hank you to all colleagues for your dedication, teamwork, and commitment throughout the year. We’re proud of what we’ve achieved together and look forward to continuing our work in 2026. Wishing everyone peaceful holidays and a joyful New Year! ✨🎁

010

Project MOTION @crgmotion.bsky.social · 23/10/2025

🌟 Exciting times for our MOTION team! We’re growing and evolving as we enter Year 3 — with new roles, fresh perspectives & shared dedication to advance hepatology and improve patient outcomes. 💪 Here’s to another year of teamwork & innovation! #MOTIONTeam #LiverResearch

010

Project MOTION @crgmotion.bsky.social · 10/10/2025

🎉 Congrats to Mathias Jachs, MD, PhD on completing his Habilitation at MedUni Vienna — an impressive milestone at such a young age! 👏 His lecture covered liver cirrhosis, CSPH & hepatitis B/D. 💪 We’re proud to have him on our MOTION team! #Hepatology

010

Project MOTION @crgmotion.bsky.social · 10/10/2025

🩸Next - WP6: Coagulation & Hemostasis Research Our specialists is working to characterize rebalanced hemostasis in #ACLD & #PSVD using advanced diagnostics like #ClotPro & TM-TGA. #Portalhypertension #coagulation #liver #Clinicaltrial

000

Project MOTION @crgmotion.bsky.social · 26/09/2025

After a long summer break, we continue introducing our work packages of project MOTION. UP next is WP5 introduced and led by @mathiasjachs.bsky.social 🖐️ Developing prognostic #NIT models for #ACLD or #PSVD 📷More info in the video below 📷

020

Project MOTION @crgmotion.bsky.social · 19/09/2025

🙌We wrapped up an amazing MOTION annual meeting! 🙌 Reflected on 2 years of growth & scientific insights, and set course for the next 2 years. Next step: making our 3 clinical trials – and project MOTION as a whole – an outstanding success! 💫 #MotionProject #TeamScience #ClinicalTrials

131

Project MOTION @crgmotion.bsky.social · 03/07/2025

👋 After a short break, we continue to introduce our WPs to you👋 Next one is MOTION WP 4 led and introduced by @mattiasmandorfer.bsky.social - Comparing #HVPG responses of our medication within our clinical trials to NSBBS... 🌐More info in the video below 📷🔽

000

Project MOTION @crgmotion.bsky.social · 06/06/2025

💫This week we are introducing WP4 & WP5 💫 Focused on HVPG response to therapy, NIT-based prognostic models, & clinical outcomes in #ACLD/#PSVD. 🔬 A comprehensive approach to #hepatology research. Led by @mattiasmandorfer.bsky.social & @mathiasjachs.bsky.social 📷More info in the graphic 📷

000

Project MOTION @crgmotion.bsky.social · 30/05/2025

🎥 Say hi to Work Package 3 of the #MotionProject! WP lead Dr. Georg Semmler gives a quick introduction into how we’re tackling PSVD—from molecular insights to clinical impact. 💡 Watch now & learn more about our mission in hepatology! #WP3 #LiverResearch #PSVD #ScienceInMotion

000

Project MOTION @crgmotion.bsky.social · 22/05/2025

🧬 WELCOME to WP3, In this WP we're exploring the molecular & prognostic characterization of PSVD using histology, metabolomics & RNA-seq. The key element: the EXPOSURE trial, investigating anticoagulation with Edoxaban in PSVD patients. #MotionProject #PSVD #WP3 #LiverResearch #ClinicalTrials

030

Project MOTION @crgmotion.bsky.social · 16/05/2025

🌐 Introducing MOTION WorkPackage 2 by @reibergerthomas.bsky.social 🌐 In this particular WP the team is focusing on decompensated cirrhosis.. #liver #PortalHypertension #clinicaltrails #dACLD 🔽 Find out more in the video below 📷🔽

021

Project MOTION @crgmotion.bsky.social · 15/05/2025

🧠 New paper by @LorenzBalcar shows that #spleenstiffness measurement (SSM) via transient elastography helps non-invasively stratify #portalhypertension in BCR::ABL1⁻ MPN — beyond #liver stiffness. A step forward in risk assessment! 📊👇More info 📊👇 lnkd.in/du8-FjgE

010

Project MOTION @crgmotion.bsky.social · 08/05/2025

Some of our Motion team members are currently at #EASL2025 in Amsterdam — proudly representing our deep expertise in liver research and innovation. Come say hi if you're around! 👋 #MotionTeam #EASL2025 #LiverResearch #Innovation #ProudToRepresent

020

Project MOTION @crgmotion.bsky.social · 08/05/2025

#Portalhypertension Fans ⬇️ 🥂🥂 OUR deputy PI @MattiasMandorf1 . received the "EASL Emerging Leader Awards 2025" in Amsterdam yesterday at #EALS2025 We congratulate him from the bottom of our #livers 😉 and are incredibly proud!

010

Project MOTION @crgmotion.bsky.social · 02/05/2025

🌐 MOTION Work Package 2 🌐 WP2 focuses on decompensated cirrhosis. Heart of the this wp is a clinical trial led by @reibergerthomas.bsky.social investigating the potential beneficial effects of norfloxacin in this patient group. ⬇️⬇️⬇️⬇️ #liver #liverdesease #PortalHypertension #ClinicalTrial

011

Project MOTION @crgmotion.bsky.social · 25/04/2025

#liver #PortalHypertension #clinicaltrails #cACLD Introducing MOTION WP 1 - Focusing on pathophysiological mechanisms in compensated Patients with liver cirrhosis.... 🌐More info in the video below 🌐 🔽🔽

010

Project MOTION @crgmotion.bsky.social · 22/04/2025

💬Introducing WP1💬 This WP focuses on the classical & alternative renin-angiotensin system as a disease-driving mechanism in patients with cACLD. The heart of WP1 is a clinical trail to investigate potentially beneficial effects of telmisartan in this patient group.

010

Project MOTION @crgmotion.bsky.social · 14/04/2025

🌐Fridays with the MOTION Team = science, smiles & serious vibes 😎🧪 Just something else.... :) 🌐 When top-notch research meets good energy, magic happens. Work hard, laugh harder — that’s how we roll. #MOTIONProject #ScienceSquad #FridayFeeling #TeamworkMakesTheDreamWork

052

Project MOTION @crgmotion.bsky.social · 11/04/2025

🌟 Our MOTION team is growing – so are our achievements! 🌟 While knowledge is undoubtedly necessary in a project, people form the foundation of success... Physicians, PhDstudents, PMs, StudyNurses & DataManagers bring their unique skills & perspectives that make our MOTION project truly special

021

Project MOTION @crgmotion.bsky.social · 09/04/2025

🥳🥳 Proud to announce that another VLSG member Nikolaus Pfisterer has successfully defended his #PhD at @meduniwien.ac.at 🙌🙌🙌 Congrats and let's celebrate!! 🙌🙌🙌

020

Project MOTION @crgmotion.bsky.social · 02/04/2025

MEET the MOTION Team! A team of clinical & basic researchers, assembled by @reibergerthomas.bsky.social & @mattiasmandorfer.bsky.social to conduct clinical studies & translational research on PH-driving molecular mechanisms. Those aspiring members are divided in 8 WPs assigned to their expertise.

030

Project MOTION @crgmotion.bsky.social · 28/03/2025

#PortalHypertension Fans !! #liver 👍 We are thrilled to share that our clinical trial is in full swing! It is divided in 8 work packages and over the upcoming weeks, we’ll introduce each innovative work package, with the dedicated experts, driving this project forward. ⬇️📷More info 📷⬇️

020

Project MOTION @crgmotion.bsky.social · 20/03/2025

🚀 Behind the abbreviation MOTION is a top-tier clinical research group at MedUni Vienna tackling portal hypertension – the key driver of liver disease morbidity & mortality. 🔬 ⬇️ Follow for more info... ⬇️ #portalhypertension #research #clinicaltrail #liver #blueskyliver

020